All In Biotech

Free tool

FAERS Monitor: Ultratag

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019981 or its brand name (Ultratag, Technetium Tc-99m Red Blood Cell Kit). Reports on generic versions are filed under their own applications.

Reports

112

Serious

4

4% of reports

Hospitalization

0

Death reported

3

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective75
  • radioisotope scan abnormal15
  • pruritus7
  • urticaria6
  • multiple gated acquisition scan abnormal5
  • radiation overdose5
  • dizziness3
  • drug monitoring procedure not performed3
  • dyspnoea3
  • erythema3
  • flushing3
  • lip swelling3
  • extravasation2
  • nausea2
  • pallor2

Reports by year received

View as table
YearReports
200813
200915
201015
201111
20128
20136
20141
20151
20162
20188
20194
20202
202121
20232
20241
20251
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,047 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple gated acquisition scan abnormalSignal524734.59918.088,519
radiation overdoseSignal519181.97788.370,485
radioisotope scan abnormalSignal154074.82529.455,876
drug monitoring procedure not performedSignal3314.2102.8649
extravasation291.423.1100
lip swellingSignal316.95.530
pallor213.83.513
drug ineffectiveSignal7510.79.4692
urticariaSignal66.73.124
flushingSignal35.51.87
pruritusSignal73.41.710
erythema32.70.92
dizziness31.10.40
dyspnoea31.00.30
nausea20.50.11

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.